CHTF
11.11.2020 17:49:06 CET | Business Wire | Press release
The 22nd High-Tech Fair (CHTF2020) kicked off at the Shenzhen Convention and Exhibition Center in Guangdong, China on November 11, 2020. The opening ceremony was attended by academicians of the Chinese Academy of Engineering, global scientists, as well as consuls of Belgium, Austria, Spain, and Poland in China.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201111005685/en/
With a 140,000m2 exhibition area, the five-day event will gather 3,300 domestic and overseas exhibitors, and present more than 140 activities. The exhibition covers various high-tech fields, including IT, energy conservation, environmental protection, building technology, new energy, new materials, smart medical care, aerospace, optoelectronic display, smart city, and advanced manufacturing. In addition, China High-Tech Forum will be held concurrently, sharing insights of world experts and the latest trends in high-tech development.
At the fair, visitors are dazzled by a large number of innovative high-tech products, such as the glass-based MiniLED that can greatly improve the display effect of LCD products, Corerain’s CAISA chip that can become an important engine in the smart era, and the graphene-reinforced composite coating that can promote the industrial application of new materials. Among them, 69 products were rated as "CHTF2020 Excellent Innovative Products".
In addition, many overseas exhibitors are eye-catching. The Russian delegation brought 17 exhibitors, including Kuzbass State Technical University and Russia Research Institute of Complex Problems of Cardiovascular Disease, to display core technologies involving radio science, 3D printing, nanomaterial, complex cardiovascular diseases, and clean energy.
The Brazilian delegation, participating in the fair for the first time, brought 29 high-tech companies to the online exhibition. They showcased their latest agricultural technologies such as the innovative sugarcane planting system, as well as digital communications, and more.
The China High-Tech Forum, as an integral part of CHTF2020, consists of multiple theme forums such as "New Era, Technology and Economy" and "Emerging Technologies Shaping the World". Academicians, top scientists and economists, as well as senior executives from well-known companies such as IBM, Huawei, Bosch, Fujitsu, Cisco, and China Mobile, delivered speeches and shared insights at the forum, focusing on technological innovation, win-win development, and post-pandemic development mode, etc.
View source version on businesswire.com: https://www.businesswire.com/news/home/20201111005685/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Echodyne Opens New Manufacturing Facility to Meet Surging Global Demand for Advanced MESA® Radar9.7.2026 15:00:00 CEST | Press release
New Washington State facility provides capacity to manufacture more than 30,000 radars annually, strengthening the U.S. defense industrial base As governments around the world accelerate investment in counter-unmanned aircraft systems (C-UAS) and short-range air defense, Echodyne today announced the opening of a new advanced radar manufacturing facility in Washington State, significantly expanding its manufacturing capacity to meet rapidly growing demand from U.S. and allied customers. With millions of drones manufactured and used by both sides in the Russian War in Ukraine, the need for enhanced safety for defense, national security, and critical infrastructure assets grows with every successful strike and interception. The low cost and high utility of drones dramatically alters the need for safety and security sensors. And as the low altitude economy takes off, hundreds of thousands of drones will perform a range of life-saving and commercial missions, requiring a sensor infrastructu
Orca Security Report: 99.9% of Fixable AI Vulnerabilities Remain Unpatched as AI Moves Into Production9.7.2026 15:00:00 CEST | Press release
Analysis of more than 1,200 production cloud environments provides a first-hand view into how organizations are embedding AI into business-critical workflows, exposing new security risks that traditional controls weren't built to address. Orca Security, a leader in cloud and AI security, today released its 2026 State of AI Security Report, offering a first-hand view into how AI is being deployed across more than 1,200 production cloud environments. The findings show AI is no longer limited to isolated pilots or developer experiments. Organizations are embedding AI into production applications, cloud services, and autonomous workflows faster than security programs can adapt. More than half (56%) of organizations have already deployed AI agents into production, while 51% use AI to build custom applications. At the same time, Orca found that 81% of organizations run vulnerable AI packages, and 99.9% of fixable AI vulnerabilities remain unpatched, highlighting how quickly AI has become ope
Viz.ai Expands into Neurodegenerative Disease with Cortechs.ai Collaboration9.7.2026 15:00:00 CEST | Press release
Cortechs.ai and Viz.ai partner to tackle multiple sclerosis and other neurodegenerative diseases across Viz.ai's health system network Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced a collaboration with Cortechs.ai, a global leader in neuroimaging and quantitative analysis solutions, to integrate Cortechs.ai's NeuroQuant and NeuroQuant MS suite into the Viz.ai platform, expanding access to quantitative neuroimaging for hospitals and health systems across the U.S. This partnership marks Viz.ai's expansion into neurodegenerative disease, growing Viz Neuro Suite beyond its already market-leading neuro offerings. The collaboration will begin with a focus on multiple sclerosis (MS), integrating quantitative MRI analysis from NeuroQuant MS directly into Viz.ai's care coordination workflow, giving clinicians both the quantitative precision and the coordination infrastructure needed to identify and manage MS patients at scale. “Viz.ai's co
SCP Standard Capital Partners AG: Fabian Becker Appointed Chairman of the Management Board and CEO9.7.2026 14:51:00 CEST | Press release
The Supervisory Board of SCP Standard Capital Partners AG (WKN: A12UPJ | ISIN: DE000A12UPJ7 | XETRA ticker: CAP) resolved today to appoint Mr. Fabian Becker as Chairman of the Management Board and Chief Executive Officer (CEO), effective as of 9 July 2026. Ms. Stephanie Schettler-Köhler will remain a member of the Management Board and will assume the role of Chief Operating Officer (COO). View source version on businesswire.com: https://www.businesswire.com/news/home/20260709982268/en/
Teva and Polpharma Biologics Announce Global Licensing Agreement for a Biosimilar Candidate to Ocrevus® (ocrelizumab) for Multiple Sclerosis9.7.2026 14:45:00 CEST | Press release
Teva secures exclusive global rights to commercialize Polpharma Biologics’ biosimilar candidate to Ocrevus® (ocrelizumab), including both intravenous and subcutaneous formulations.Agreement advances Teva’s Pivot to Growth strategy by expanding its biosimilars pipeline through strategic collaborations.Agreement reflects both companies’ commitment to broadening access to biologic medicines. Teva Pharmaceuticals International GmbH, a subsidiary of Teva Pharmaceutical Industries Ltd (NYSE: and TASE: TEVA) and Polpharma Biologics International AG today announced a global licensing agreement granting Teva exclusive rights to commercialize both formulations of Polpharma Biologics’ proposed biosimilar to Ocrevus®1 (ocrelizumab), upon regulatory approval. This strategic agreement is expected to combine Polpharma Biologics’ proven biosimilar development expertise with Teva’s commercial footprint and capabilities. This press release features multimedia. View the full release here: https://www.bus
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom